No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Do Not Improve Survival Free of Organ Support in COVID-19

byAstrid BradshawandAlisha Yi

September 18, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Do Not Improve Survival Free of Organ Support in COVID-19

Click here to read this study in The Lancet.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

101-PGC-005 improved hospitalized patients with COVID-19 faster than systemic dexamethasone in topline phase 2/3 results

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Praxis Precision’s relutrigine reduces seizures in rare epileptic disorders in phase 2 clinical trials

RelatedReports

A balance scale weighing an antiviral medication against a hospital entrance and a patient, symbolizing the outcomes of COVID-19 treatment.

2MM Trial Briefs

101-PGC-005 improved hospitalized patients with COVID-19 faster than systemic dexamethasone in topline phase 2/3 results

November 10, 2026

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026

Atrial fibrillation collage: an engraved heart with teal upper chambers, paper sparks and a dotted teal ribbon around it

Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026

Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026

Risk factors for recurrent firearm injury among children

#VisualAbstract: Lu AG09222, a Monoclonal Antibody Targeting Pituitary Adenylate Cyclase-Activating Polypeptide, Reduced Migraine Episodes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Do Not Improve Survival Free of Organ Support in COVID-19

101-PGC-005 improved hospitalized patients with COVID-19 faster than systemic dexamethasone in topline phase 2/3 results

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Praxis Precision’s relutrigine reduces seizures in rare epileptic disorders in phase 2 clinical trials

Sedentary behaviour associated with various forms of mortality and cancers in a United Kingdom cohort

RelatedReports

101-PGC-005 improved hospitalized patients with COVID-19 faster than systemic dexamethasone in topline phase 2/3 results

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Sedentary behaviour associated with various forms of mortality and cancers in a United Kingdom cohort

Risk factors for recurrent firearm injury among children

#VisualAbstract: Lu AG09222, a Monoclonal Antibody Targeting Pituitary Adenylate Cyclase-Activating Polypeptide, Reduced Migraine Episodes

2MM+ All Access

Recent Reports

Get the app

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits